dicyandiamido has been researched along with Body Weight in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CY; Cheng, CH; Chern, JH; Chuu, JJ; Huang, CH; Huang, ZN; Li, SL; Lien, HY; Lin, CC; Wu, YY | 1 |
Kitaura, K; Mitsumori, K; Onodera, H; Shimo, T; Takahashi, M; Yasuhara, K | 1 |
2 other study(ies) available for dicyandiamido and Body Weight
Article | Year |
---|---|
Antitumor effect of BPR-DC-2, a novel synthetic cyclic cyanoguanidine derivative, involving the inhibition of MDR-1 expression and down-regulation of p-AKT and PARP-1 in lung cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Body Weight; Bromodeoxyuridine; Carcinoembryonic Antigen; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Guanidines; Humans; In Situ Nick-End Labeling; Lung; Lung Neoplasms; Mice; Mice, Nude; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; Survival Analysis | 2011 |
Lack of carcinogenicity of cyanoguanidine in F344 rats.
Topics: Administration, Oral; Animals; Body Weight; Carcinogenicity Tests; Eating; Female; Guanidines; Male; Neoplasms; Rats; Rats, Inbred F344; Survival Rate | 1997 |